Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial

Autor: Tran, Pierre, Skolnick, Phil, Czobor, Pal, Huang, N.Y., Bradshaw, Mark, McKinney, Anthony, Fava, Maurizio
Zdroj: In Journal of Psychiatric Research January 2012 46(1):64-71
Databáze: ScienceDirect